Bloomberg reports that Fosun International is reviving plans to sell its majority stake in the Hong Kong-based reinsurer, aiming for a US$1bn valuation.
The Competition Commission of India has provided full approval for Zurich's phased acquisition, first announced in November, starting with 51% in 2024, and a further 19% within three years.